The Company and Basis of Presentation (Details) - Schedule of Company’s Entity Structure at the End of the Reporting Period |
12 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Neuphoria Therapeutics Inc. [Member] | |
| Schedule of Company's Entity Structure at the End of the Reporting Period [Line Items] | |
| Entity | Parent |
| Country of Incorporation | United States |
| Bionomics Limited [Member] | |
| Schedule of Company's Entity Structure at the End of the Reporting Period [Line Items] | |
| Entity | Subsidiary |
| Country of Incorporation | Australia |
| Bionomics, Inc. [Member] | |
| Schedule of Company's Entity Structure at the End of the Reporting Period [Line Items] | |
| Entity | Subsidiary |
| Country of Incorporation | United States |